BioCentury
ARTICLE | Company News

Athera, Dyax deal

October 6, 2008 7:00 AM UTC

The companies will partner to discover and develop antibodies against phosphorylcholine (PC) to prevent or treat cardiovascular diseases such as atherosclerosis. Dyax will use its antibody libraries ...